Defining genetic diversity of rhesus macaque Fcγ receptors with long-read RNA sequencing.

Fc receptor FcγR SNPs FcγR structures Long-read RNA sequencing genetic diversity rhesus macaques

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 03 10 2023
accepted: 20 12 2023
medline: 24 1 2024
pubmed: 24 1 2024
entrez: 24 1 2024
Statut: epublish

Résumé

Fcγ receptors (FcγRs) are membrane-bound glycoproteins that bind to the fragment crystallizable (Fc) constant regions of IgG antibodies. Interactions between IgG immune complexes and FcγRs can initiate signal transduction that mediates important components of the immune response including activation of immune cells for clearance of opsonized pathogens or infected host cells. In humans, many studies have identified associations between FcγR gene polymorphisms and risk of infection, or progression of disease, suggesting a gene-level impact on FcγR-dependent immune responses. Rhesus macaques are an important translational model for most human health interventions, yet little is known about the breadth of rhesus macaque FcγR genetic diversity. This lack of knowledge prevents evaluation of the impact of FcγR polymorphisms on outcomes of preclinical studies performed in rhesus macaques. In this study we used long-read RNA sequencing to define the genetic diversity of FcγRs in 206 Indian-origin Rhesus macaques,

Identifiants

pubmed: 38264644
doi: 10.3389/fimmu.2023.1306292
pmc: PMC10803544
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1306292

Informations de copyright

Copyright © 2024 Conley, He, Easterhoff, Kirshner, Cocklin, Meyer, Hoxie, Berry, Bradley, Tolbert, Pazgier, Tomaras, Schmitz, Moody, Wiehe and Pollara.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Auteurs

Haleigh E Conley (HE)

Department of Surgery, Duke University School of Medicine, Duke University, Durham, NC, United States.
Duke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.

Max M He (MM)

Duke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.

David Easterhoff (D)

Duke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.

Hélène Fradin Kirshner (HF)

Duke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.

Sarah L Cocklin (SL)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

Jacob Meyer (J)

Duke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.

Taylor Hoxie (T)

Duke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.

Madison Berry (M)

Duke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.

Todd Bradley (T)

Genomic Medicine Center, Children's Mercy Kansas City, Kansas City, MO, United States.

William D Tolbert (WD)

Infectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.

Marzena Pazgier (M)

Infectious Disease Division, Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.

Georgia D Tomaras (GD)

Department of Surgery, Duke University School of Medicine, Duke University, Durham, NC, United States.
Duke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.

Joern E Schmitz (JE)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States.

Michael Anthony Moody (MA)

Duke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.

Kevin Wiehe (K)

Duke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.

Justin Pollara (J)

Department of Surgery, Duke University School of Medicine, Duke University, Durham, NC, United States.
Duke Human Vaccine Institute, Duke University School of Medicine, Duke University, Durham, NC, United States.

Classifications MeSH